Search

Author/Creator Horak, Ivan D.

1. Forty‐nine gastric cancer cell lines with integrative genomic profiling for development of c‐MET inhibitor. Issue 1 (23rd February 2018)

Authors:
Kim, Hyun Jeong; Kang, Sun Kyoung; Kwon, Woo Sun; Kim, Tae Soo; Jeong, Inhye; Jeung, Hei‐Cheul; Kragh, Michael; Horak, Ivan D.; Chung, Hyun Cheol; Rha, Sun Young
Journal:
International journal of cancer
Issue:
Volume 143:Issue 1(2018)
Page Start:
151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration2. (January 2022)

Authors:
Pearson, Andrew DJ.; Rossig, Claudia; Mackall, Crystal; Shah, Nirali N.; Baruchel, Andre; Reaman, Gregory; Ricafort, Rosanna; Heenen, Delphine; Bassan, Abraham; Berntgen, Michael; Bird, Nick; Bleickardt, Eric; Bouchkouj, Najat; Bross, Peter; Brownstein, Carrie; Cohen, Sarah Beaussant; de Rojas, T...
Journal:
European journal of cancer
Issue:
Volume 160(2022)
Page Start:
112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pan‐HER—An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand‐induced EGFR homo‐ and heterodimers. Issue 9 (19th July 2016)

Authors:
Ellebæk, Sofie; Brix, Susanne; Grandal, Michael; Lantto, Johan; Horak, Ivan D.; Kragh, Michael; Poulsen, Thomas Tuxen
Journal:
International journal of cancer
Issue:
Volume 139:Issue 9(2016:Nov. 01)
Page Start:
2095
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗